Jasper TherapeuticsJSPR
那斯達克 · USD
0.90
+0.03
(+3.48%)
收盤 05/23 03:02 (UTC+8)
05/23 03:02 (UTC+8)
Jasper TherapeuticsJSPR
0.90
+0.03
(+3.48%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 10,952 | 15,839 | 19,166 | 27,076 | - | - | 19,889 | - | 15,072 | 17,725 |
研發費用 | 5,814 | 11,360 | 14,391 | 21,196 | 16,157 | 19,772 | 14,455 | 11,296 | 10,298 | 13,835 |
推銷及管理費用 | 5,138 | 4,479 | 4,775 | 5,880 | 5,645 | 5,513 | 5,434 | 4,697 | 4,774 | 3,890 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -10,952 | -15,839 | -19,166 | -27,076 | -21,802 | -25,285 | -19,889 | -15,993 | -15,072 | -17,725 |
其他收入及費用 | - | 6,738 | 430 | 353 | 561 | 964 | 1,252 | 1,410 | 1,344 | 1,144 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -1,174 | -9,101 | -18,736 | -26,723 | -21,241 | -24,321 | -18,637 | -14,583 | -13,728 | -16,581 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -1,174 | -9,101 | -18,736 | -26,723 | -21,241 | -24,321 | -18,637 | -14,583 | -13,728 | -16,581 |
基本每股稅後盈餘(元) | -0.04 | -0.32 | -1.13 | -1.74 | -1.41 | -1.62 | -1.24 | -0.97 | -1.03 | -0.15 |
稀釋每股稅後盈餘(元) | -0.04 | 0.23 | -1.02 | -1.75 | -1.41 | -1.64 | -1.25 | -0.97 | -1.03 | -0.15 |
基本平均股數(千股) | 28671.00 | 28663.00 | 16635.00 | 15333.00 | 15022.00 | 15008.00 | 15000.00 | 14986.00 | 13334.00 | 110445.00 |
稀釋平均股數(千股) | 28671.00 | 28663.00 | 16635.00 | 15333.00 | 15022.00 | 15008.00 | 15000.00 | 14986.00 | 13334.00 | 110445.00 |
還原基本每股稅後盈餘(元) | -0.04 | -0.32 | -1.13 | -1.74 | -1.41 | -1.62 | -1.24 | -0.97 | -1.03 | -1.50 |
還原稀釋每股稅後盈餘(元) | -0.04 | 0.23 | -1.02 | -1.75 | -1.41 | -1.64 | -1.25 | -0.97 | -1.03 | -1.50 |
還原基本平均股數(千股) | 28,671 | 28,663 | 16,635 | 15,333 | 15,022 | 15,008 | 15,000 | 14,986 | 13,334 | 11,044 |
還原稀釋平均股數(千股) | 28,671 | 28,663 | 16,635 | 15,333 | 15,022 | 15,008 | 15,000 | 14,986 | 13,334 | 11,044 |
EBITDA(千元) | -1,153 | -8,811 | -18,507 | -26,465 | -20,962 | -24,076 | -18,096 | -14,284 | -13,440 | -16,298 |